Is There Still an Adderall Shortage? (2023 Update)

Updated on September 18, 2023
 by — reviewed by Jason Williams, PhD (Contributor: George Collins / Editor: Yoko Hill)
adderall shortage

Is there still an Adderall shortage?

If you or someone you know has been affected by ADHD, you may be well aware of the ongoing Adderall shortage. Despite the announcement of supply troubles by the FDA months ago, many individuals are still struggling to access this widely prescribed stimulant medication.

With the demand outweighing the availability, patients are left scrambling, rationing, or even going without their essential medication.

In this article, we will explore the reasons behind the continued Adderall shortage and shed light on the complexities of resolving such a heavily regulated drug supply issue.

Understanding the Adderall Shortage

Adderall is a widely prescribed medication used to treat attention deficit hyperactivity disorder (ADHD).

It contains a combination of amphetamine salts, which help to improve focus, attention, and impulse control in individuals with ADHD.(1)

Because of its effectiveness, Adderall is distributed all across the country. However, there are many people are wondering when will the Adderall shortage be over...

The Adderall shortage crisis refers to the limited availability of this medication in the United States.

In October 2022, the FDA announced that companies producing amphetamine mixed salts, the active ingredient in Adderall, were experiencing manufacturing delays or not producing enough to meet the demand.

This shortage primarily affected individuals who rely on Adderall to manage their ADHD symptoms.

Here are some key points to understand about the situation: 

  • Lack of Clarity and Transparency: The Adderall crisis is challenging to fully comprehend due to the lack of transparency in the drug manufacturing supply chain. The FDA announcement provided little specific information, leaving patients and healthcare professionals with limited explanation. The drug companies responsible for production have no obligation to disclose detailed updates, exacerbating the confusion surrounding the shortage.
  • Implications of the Shortage: Shortages of essential medications, like Adderall, increase pressure on manufacturers and suppliers to meet unpredicted surges in demand. As a result, patients who genuinely require the medication find themselves competing with illicit drug users for a limited supply, leading to increased prices on the black market. This shortage also presents an opportunity for individuals struggling with Adderall addiction to reconsider their usage and seek alternatives, potentially aiding in their recovery.
  • Navigating the Pharmaceutical Supply Chain: Understanding the complexities of the pharmaceutical supply chain is crucial in comprehending the Adderall shortage. Oversight of the manufacturing process, regulatory concerns, distribution challenges, and inventory management all play a significant role in ensuring a steady supply of medications. However, when disruptions occur, such as manufacturing delays or increased demand, the supply chain can falter, affecting patients who rely on these essential medications.

Overall, the Adderall shortage crisis poses challenges for individuals who depend on this medication to manage their ADHD symptoms.

The lack of transparency within the drug manufacturing supply chain and the resulting limited availability of the drug contribute to a complex and ongoing issue.

It highlights the need for increased oversight and effective management to mitigate the impact of drug shortages on patients' well-being

The Current Status of the Adderall Shortage

As of the most recent update, there is an ongoing shortage of the immediate-release formulation of mixed amphetamine salts, commonly known as Adderall.

The FDA confirmed this shortage on October 12, 2022. This shortage primarily affects the immediate-release version of the medication. The shortage has persisted, and it still remains challenging to obtain Adderall and other amphetamine-mixed salts.

The current status of the Adderall shortage remains a topic of concern for patients relying on this common treatment for attention-deficit/hyperactivity disorder (ADHD).

One of the manufacturers, Teva, is experiencing intermittent manufacturing delays, contributing to the ongoing scarcity of Adderall. However, other manufacturers are still producing amphetamine mixed salts, though in limited quantities.

The current status of the Adderall shortage remains a topic of concern for patients relying on this common treatment for attention-deficit/hyperactivity disorder (ADHD).

The FDA is actively monitoring the supply and working with manufacturers to address the shortage. They have pledged to provide further updates as new supply information becomes available.

For more detailed information, it's advisable to check the FDA's drug shortage list regularly.

Factors Contributing to the Adderall Shortage

There are multiple factors collectively contributing to the ongoing shortage of Adderall.

These key factors include: 

  • Production Issues: One significant factor contributing to the shortage of Adderall is manufacturing problems. The production of medications like Adderall is a complex process that involves multiple stages. Any disruptions or inefficiencies during production can lead to a decrease in supply. In the case of Adderall, the manufacturing problems initially sparked the shortage.
  • Demand and Supply Imbalance: Another factor impacting the availability of Adderall is the imbalance between demand and supply. The ADHD drug has witnessed a surge in demand over the years, with millions of Americans relying on it to manage their ADHD symptoms. However, the supply capacity has not kept up with the increasing demand, leading to prolonged shortages.
  • Regulatory Constraints: Adderall contains amphetamine, an active ingredient that is classified as a controlled substance under federal law. The regulation of controlled substances aims to prevent abuse and misuse. However, these regulatory constraints can also limit the production and availability of medications like Adderall. The government sets quotas and restricts production to ensure controlled substances are not excessively distributed.
  • Raw Material Scarcity: Adderall requires specific raw materials to be manufactured. If there is a scarcity or shortage of these raw materials, it can severely impact the production of the drug. For instance, if there is limited capacity in the market to provide the necessary raw materials, it can result in a shortage of Adderall even if the demand remains high.

Impact of the Adderall Shortage

The Adderall shortage has had a significant impact on patients, healthcare providers, and the healthcare system as a whole.

As the shortage continues, patients who rely on Adderall for ADHD treatment face challenges in accessing their medication. This not only disrupts their patient care but also puts their mental health and overall well-being at risk.

For healthcare providers, the shortage poses a dilemma in terms of finding suitable alternative medications for their patients. They are forced to explore other options such as digital therapeutics and non-stimulants, which may not be as effective or preferred by patients. 

Moreover, the Adderall shortage has caused a disruption in the healthcare system. With drugmakers urged to boost production, there is an increased strain on the pharmaceutical industry to meet the demand.

This sudden surge may result in supply chain challenges and potential delays in medication availability.

The healthcare system must adapt to these challenges and find ways to ensure patients receive the necessary ADHD treatment despite the shortage.

To mitigate the impact of the shortage, it is crucial for all stakeholders, including manufacturers, distributors, pharmacies, and payors, to collaborate and work together.

They must address the issue swiftly and find solutions that prioritize patient care. This may involve developing diagnostic criteria for ADHD in adults, re-evaluating drug quota allotments, and promoting the adoption of non-stimulant alternatives.

Alternatives to Adderall

Some individuals are wondering how to get Adderall during the shortage - and due to the issue persisting, they have turned to over-the-counter alternatives to prescribed stimulant medication. This is helping hundreds of patients with ADHD to effectively manage their symptoms.

These supplements offer potent cognitive-enhancing effects, with fewer side effects than prescription medications.

To help you manage your ADHD symptoms and achieve optimal cognitive health during this Adderall crisis, here is a list of 4 popular alternatives to Adderall to consider: 

  1. Vyvamind (Potent and Reliable): Vyvamind is rapidly gaining popularity as a top OTC natural Adderall alternative. This supplement is known for its potency, reliability, and safety profile. It was specifically formulated to mimic the main beneficial effects of Adderall, and includes natural nootropics like caffeine.(2) Vyvamind provides powerful neurostimulation, enhances neurotransmitter balance, and helps maintain brain cell health. Not only does it improve focus, but it also reduces stress and has fewer side effects compared to prescription drugs for ADHD.
  2. Nooceptin (Improved Cognition Naturally): Nooceptin is an excellent option for individuals seeking a cognitive enhancer without the risks associated with amphetamine-based medications like Adderall. This natural alternative combines seven powerful Nootropic supplements to improve cognitive performance and brain functioning abilities. One of its key ingredients, alpha glycerylphosphorylcholine,(3) is known to provide similar benefits to amphetamine-based drugs, such as improved focus and cognitive abilities.
  3. NooCube (Effective and Safe): NooCube is a potent nootropic and one of the best natural OTC Adderall replacement pills available. Its all-natural components aid in enhancing brain health and cognitive functioning. Noocube contains a blend of ingredients that have been carefully selected for their cognitive-enhancing properties. This supplement is widely regarded for its effectiveness and safety, making it a great alternative to Adderall.
  4. Mind Lab Pro (Top-notch Potency): Mind Lab Pro consistently ranks at the top of the "best Adderall alternatives" lists. This supplement stands out due to its top-notch potency, clean ingredients list, and extensive clinical research. Mind Lab Pro is designed to enhance cognitive performance and optimize brain function. It provides a comprehensive blend of ingredients that work synergistically to support memory, focus, and overall cognitive abilities.

However, it is important to note that individual responses may vary, and it is always best to consult with a healthcare professional before starting any new supplement regimen.


Based on online data, it appears that there may still be sporadic shortages of Adderall in certain regions in February 2023. While the overall availability of the drug is expected to improve compared to previous months, the supply remains in short supply across much of the country.

The issue of the Adderall shortage also raises questions about the impact it has on individuals who rely on the drug for the treatment of ADHD. The shortage may disrupt their treatment plans and access to medication.

It is crucial for healthcare providers to closely monitor and manage the situation to ensure that patients receive the necessary treatment and support.

While there may be ongoing efforts to address the Adderall shortage, it is essential for the public to remain informed. It is recommended to continue using all available tools to help keep the supply available for patients.

For those looking for an immediate answer, there are nootropics like Adderall to consider that are just as effective in many cases. Additionally, they may provide a better option for those who struggle with addiction to Adderall.